GCKR and metabolic dysfunction-associated steatotic liver disease: Third, the NAFLD risk variant GCKR (P446L) is associated with higher levels of plasma low-density lipoprotein cholesterol and triglycerides and lower fasting glucose and homeostasis model assessment parameter (HOMA)-IR [30].